What CAM Bioceramics does

CAM Bioceramics B.V. is a privately held Dutch Contract Development and Manufacturing Organization (CDMO) specializing in calcium phosphate bioceramic materials for medical device applications. Founded in the 1980s and headquartered in Leiden, the Netherlands, the company pioneered hydroxyapatite (HA) plasma-sprayed coatings for orthopedic implants and has since built a 35+ year track record across virtually every calcium phosphate chemistry used in medical devices. Its operations span in-house raw material production, chemical synthesis, spray drying, sintering, milling, and sieving, with full QC capabilities including XRD, FTIR, SEM, laser diffraction, and S-BET surface characterization.

The company sells four primary product lines — HA Powders, HA/β-TCP biphasic powders, β- and α-TCP powders, and HA/HA-β-TCP granules — to medical device OEMs across five verticals: orthopedic implant coatings, orthopedic/spine/dental bone void fillers, injectable dermal fillers and skinboosters (aesthetics), 3D printing/additive manufacturing of patient-specific implants, and excipients/drug delivery. Products are fully customizable along parameters including Ca/P ratio, porosity, particle size, morphology, and degradation rate. CAM is ISO 13485:2016 certified, GMP-compliant, ANVISA-certified for Brazil, and holds Ecovadis sustainability certification, with stated compliance to ASTM F1185, ASTM F1088, ISO 13779-6, ISO 13175-3, and ISO 13320.

The business model is B2B custom contract manufacturing: revenue is generated through negotiated, project-based supply agreements with industry-leading medical device OEMs, with pricing tied to specifications, volumes, and customization rather than publicly disclosed list prices. The company operates a direct, consultative enterprise sales motion supported by a 51–100 person organization led by CEO Hans van Donge and a dedicated R&D and QA/QC/RA function. As an independent, privately held company with no disclosed funding rounds or institutional investors, CAM Bioceramics is positioned as a specialized, deeply regulated upstream supplier in the medtech biomaterials value chain rather than a high-velocity growth-stage business.

Name

CAM Bioceramics

Legal name

CAM Bioceramics B.V.

Website

https://cambioceramics.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

51–100 employees

Short description

CAM Bioceramics is a Dutch CDMO founded in the 1980s that designs, develops, and manufactures customized calcium phosphate powders and granules for medical device OEMs serving orthopedic, dental, aesthetic, 3D printing, and drug delivery markets.

Ownership category

akta.pro rank

Product category

Bioceramic Materials

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring) (HLAAAJAD)

Keywords

• Calcium phosphate manufacturing
• Bioceramic materials
• Orthopedic implant coatings
• Hydroxyapatite powders
• Contract development manufacturing

Headquarters

HQ city

Leiden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Custom Calcium Phosphate Product Manufacturing: CAM Bioceramics operates as a CDMO, manufacturing customized calcium phosphate solutions for medical device applications. Revenue is generated through the sale of engineered powders, granules, and related products tailored to customer specifications, serving orthopedic, dental, aesthetic, and other medical markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CAM Bioceramics is a Contract Development and Manufacturing Organization (CDMO) that designs, develops, and manufactures customized calcium phosphate bioceramic products—including Hydroxyapatite (HA), β-TCP, α-TCP, and biphasic HA/TCP powders and granules—for medical device applications in orthopedic implant coatings, bone void fillers, dental, aesthetic injectables, excipients/drug delivery, and additive manufacturing/3D printing. The company offers end-to-end support from R&D co-development through full-scale production, tailoring parameters such as Ca/P ratio, porosity, particle size, morphology, and degradation rate to customer specifications.

Product overview

CAM Bioceramics is a Contract Development and Manufacturing Organization (CDMO) specializing in premium calcium phosphate solutions. The product portfolio comprises four main product lines: HA Powders (Hydroxyapatite) for implant coatings and aesthetic applications, HA/β-TCP Powders (biphasic compound), β- and α-TCP Powders for resorbable fixations and bone cements, and HA/β-TCP Granules for bone void fillers. These materials serve five key application areas: Orthopedic Implant Coating, Orthopedic/Spine/Dental applications, Excipient (drug delivery), Aesthetics (dermal fillers), and Additive Manufacturing (3D printing). The products are customized based on Ca/P ratio, porosity, particle size, morphology, and other parameters to meet specific customer requirements.

Differentiator

Problem solved

Functional benefit

Products and services

• HA Powders (Hydroxyapatite Powders) Spherical Hydroxyapatite (HA) powders engineered for medical aesthetics and implant coatings. The line includes HA Coating Powders designed for osseointegration on orthopedic implants, Large Soft Tissue Fillers (75-125 µm), and Small Soft Tissue Fillers (25-45 µm for dermal fillers and 15-25 µm for skinboosters). Customizable parameters include Ca/P ratio, particle size distribution, morphology, and surface area.
• HA/β-TCP Powders (Biphasic Compound Powders) Biphasic HA/TCP compound powder with a fully reticulated porous structure, serving as an ideal basis for bone void fillers with osteoconductive properties that are completely replaced by new bone over time. Targeted at orthopedic, spine, dental, and bone regeneration applications.
• β- and α-TCP Powders (Tricalcium Phosphate Powders) Specialty tricalcium phosphate powders including β-TCP Compound Powder (20-60 µm via spray drying with a highly porous surface for processing with polymers in medical implant composites), Milled β-TCP Powder (<5 µm mean particle size, narrow PSD, no particles >10 µm), and α-TCP Cement Powder (<5 µm for high-reactivity bone cement applications).
• HA- and HA/β-TCP Granules (Bone Void Filler Granules) Porous granules for bone void fillers available in sizes from less than 50 microns to over 1000 microns. Includes β-TCP granules with macropores (~600 µm) optimized for accelerated resorption and bone formation in orthopedic, spine, and dental regenerative applications.

Quantifiable outcome

• HA coatings applied to millions of implants globally
• +1 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered minor.

• HiMEDminorOthersListed as a key player in the biodegradable implant succinic coatings market alongside CAM Bioceramics. This appears to be a market positioning reference rather than an explicit partnership.
• HydromerminorOthersListed as a key player in the biodegradable implant succinic coatings market alongside CAM Bioceramics. This appears to be a market positioning reference rather than an explicit partnership.
• Medicoat AGminorOthersListed as a key player in the biodegradable implant succinic coatings market alongside CAM Bioceramics. This appears to be a market positioning reference rather than an explicit partnership.
• APS Materials, Inc.minorOthersListed as a key player in the biodegradable implant succinic coatings market alongside CAM Bioceramics. This appears to be a market positioning reference rather than an explicit partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Curasan: German manufacturer of synthetic bone regeneration materials including calcium phosphate-based bone graft substitutes for dental and orthopedic indications. Direct competitor in biomaterial CDMO space.
• Medicoat AG: Swiss provider of HA plasma spray coating services and materials for orthopedic implants. Listed alongside CAM as a key player in the same biodegradable coatings market.
• DOT GmbH: German company specializing in calcium phosphate coatings for medical implants, with overlapping capabilities in plasma spray coating powders. Direct competitor in the implant coating materials segment.
• APS Materials Inc. US-based provider of plasma spray coating services and ceramic coating powders for medical implants. Listed in the same competitive set as CAM in implant coatings.
• Botiss Biomaterials: German specialist in dental and orthopedic biomaterials including synthetic bone graft substitutes based on calcium phosphate chemistry. Comparable product mix and CDMO business model.
• Berkeley Advanced Biomaterials (BAB): US-based specialist in synthetic calcium phosphate bone graft materials and bioceramic powders serving orthopedic, dental, and craniofacial markets. Closely comparable product portfolio and customer base to CAM.
• Plasma Biotal: UK-based manufacturer of calcium phosphate biomaterials including HA and TCP powders for orthopedic and dental applications. Direct competitor to CAM Bioceramics in custom calcium phosphate CDMO services.

Broad incumbents

• DSM Biomedical: Dutch biomaterials division of DSM (now dsm-firmenich) offering a broader portfolio of biomedical polymers and ceramics including calcium phosphate materials. Larger incumbent with overlapping capabilities.
• Evonik (Health Care): German specialty chemicals major with a Health Care division supplying specialty excipients, APIs, and biomaterials for pharmaceutical and medical device applications. Larger player with adjacent offerings.
• Kyocera (Medical & Bioceramics): Japanese ceramics multinational with a dedicated medical and bioceramic division producing HA coatings, ceramic implants, and dental prosthetics. Much larger diversified incumbent in adjacent bioceramics markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInnl.linkedin.com/company/cam-bioceramics-b.v.

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAM Bioceramics